Observational, Epidemiological and Non Interventional Study Evaluating the Evolution of Lung Cancer Related Symptoms and Its Correlation With Disease Control Rate in Patients With Non-Small Cell Lung Cancer (NSCLC) Initiating First-line Treatment With Platinum Based Standard Chemotherapy.
Phase of Trial: Phase IV
Latest Information Update: 04 Mar 2016
At a glance
- Drugs Bevacizumab (Primary) ; Platinum complexes
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Roche
- 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Sep 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 28 May 2011 New trial record